Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep231 | Calcium and Bone | ECE2022

Association between serum magnesium levels and physical performance tests in patients with primary osteoporosis

Iulia Greere Daniela Ioana , Voicu Gabriela , Manda Dana Alice , Poiană Cătălina

Introduction: Osteoporosis is the most frequent metabolic bone disease worldwide affecting primarily the senior population. The associated bone loss in combination with a decline in physical performance lead to increased incidence of falls and fragility fractures. Thus, improving physical performance is key to preventing osteoporotic fractures.Methods: A total of 140 participants were inrolled in a cross-sectional study. Secondary causes of osteoporosis ...

ea0067o7 | Oral Presentations | EYES2019

Coexistence of medullary carcinoma and papillary carcinoma of the thyroid in a 35 year old patient with RET protooncogene mutation

Nuţu Flavia Giselle , Duşceac Roxana , Poiană Cătălina

Background: Medullary and papillary thyroid carcinomas are distinct entities, regarding their incidence, cellular and genetic origin, histopathological features and prognosis, but there have been described a few cases of the two occurring simultaneously in the same patient. Medullary thyroid carcinoma represents between 1–5% of all thyroid malignancies and it is responsible for 12–13% of all cancer related deaths. The familial form (10–20% of the cases) is cause...

ea0063p1174 | Thyroid 3 | ECE2019

Intra-tumoral necrosis after Sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer: what’s next?

Manole Diandra Carmen , Baciu Ionela , Morea Alexandru , Dumitrascu Anda , Poiană Cătălina

Introduction: Radioactive iodine-refractory differentiated thyroid cancer is a rare form of advanced thyroid cancer (approximately 4 cases per million population per year) defined by persistent disease after administration of a cumulative radioiodine dose of 600 mCi or at least one tumor without radioactive iodine uptake or by progression of the disease within one year after RAI treatment. Therapeutic options in this case include molecular-targeted therapies, like tyrosine kin...

ea0070aep727 | Pituitary and Neuroendocrinology | ECE2020

Multiple metastatic NET of unknown primary site in a young patient with carcinoid syndrome: Can we treat it as a gastrointestinal NET?

Lambrinoc Diana , Morea Alexandru , Dușceac Roxana , Poiană Cătălina

Introduction: Neuroendocrine tumours (NETs) of unknown primary site are relatively uncommon, representing about 10% of all NETs. Of these, particularly the well-differentiated NETs often present initially with liver metastases, and most of these represent gastroenteropancreatic NETs. The presence of carcinoid syndrome is also common.Case presentation: We describe the case of a 40 years-old patient presented in 2013 with flushing, diarrhea, and back pain....

ea0073aep145 | Calcium and Bone | ECE2021

Adjuvant endocrine therapy impact on bone health in premenopausal women with hormone receptor-positive breast cancer: Results of a case series

Lambrinoc Diana , Roxana Duşceac , Morea Alexandru , Cătălina Poiană

IntroductionAdjuvant endocrine therapy has an important role in the management of hormone receptor-positive (expressing oestrogen/progesterone receptors) early-stage breast cancer, reducing the risk of recurrence and improving associated mortality. The estradiol depletion produced by hormone therapy has detrimental effects on skeletal health, which can lead to low bone mineral density (BMD), altered bone microarchitecture and increased risk of fracture.<...

ea0086p172 | Adrenal and Cardiovascular | SFEBES2022

Silent clinical picture at diagnosis in incidentally discovered large pheochromocytomas

Arbunea-Ghenoiu Sandra , Căpăţină Cristina , Poiană Cătălina

Introduction: Pheochromocytoma is an adrenal medullary tumor which typically involves nonspecific symptoms like arterial blood hypertension, tachycardia, headache or sweating. In some cases, patients may be completely asymptomatic at onset and exceptionally develop symptoms after surgery.Case presentation: We present two cases, first one of a 36 years old male, in which an MRI scan for evaluation of the spine revealed an oval, well-contoured heterogeneou...

ea0067gp25 | Poster Presentations | EYES2019

Atypical presentation of an acromegalic patient

Verdeş Andreea Maria , Căpăţ C , Poiană Cătălina

Background: Acromegaly is a rare disorder, with a prevalence of 6 cases of 100000 and an annual incidence of 3–4 new cases of one million. It is almost always the consequence of GH secreting pituitary adenomas and, rarely, caused by nontumoral somatotrophic hyperplasia.Case presentation: 54 years old patient, heavy smoker, hypertensive, dyslipidemic, obese, presents in June 2019 with unspecific symptoms: physical asthenia, hypersomnia (falls asleep ...

ea0067gp26 | Poster Presentations | EYES2019

Multiple endocrine neoplasia type 1 presented with gastric neuroendocrine tumor: a case report

Lambrinoc Diana , Morea Alexandru , Burcea Iulia Florentina , Duşceac Roxana , Poiană Cătălina

Background: Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome, characterized by primary MEN1 tumors: parathyroid, pancreatic and pituitary. We describe the case of a patient with MEN1 syndrome, initially presented with a gastric neuroendocrine tumor (NET).Case presentation: A 33-year-old male patient, initially treated for perforated gastric ulcer, presented 7 years later with dyspepsia, diarrhea and weight loss. Abdominal CT scan revea...

ea0077p219 | Neuroendocrinology and Pituitary | SFEBES2021

Pituitary apoplexy- a retrospective analysis of clinical features, management and outcomes

Ghenoiu Sandra , Ciubotaru Gheorghe Vasile , Dumitraucu Anda , Căpăt.ină Cristina , Poiană Cătălina

Introduction: The term “pituitary apoplexy” (PA) describes the appearance of abrupt hemorrhage and/or ischaemia of the constituents of sella turcica, usually in a pre-existing pituitary tumor. The presentation of this syndrome may be acute or subclinical.Objective: This study aims to assess clinical, imaging and hormonal features and the outcomes following surgery or conservative treatment among pituitary adenoma patients presenting with PA.</p...

ea0050ep016 | Adrenal and Steroids | SFEBES2017

‘Connshing syndrome’ as a cause of hypertension: case report

Lefter Antonia , Căpăt´ană Cristina , Deciu Diana , Radian Şerban , Poiană Cătălina

Introduction: An association between primary hyperaldosteronism and autonomous cortisol secretion, tentatively termed ‘Connshing’ syndrome, is becoming increasingly recognized.Aim: To present a case of primary hyperaldosteronism associated with ACTH-independent subclinical Cushing’s.Methods: Clinical examination, biochemical testing and imaging studies.Results: A 49-y...